beta-thujaplicin has been researched along with 2019 Novel Coronavirus Disease in 2 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohara, H | 1 |
| Odanaka, K | 1 |
| Shiine, M | 1 |
| Hayasaka, M | 1 |
| Hoang, BX | 1 |
| Han, B | 1 |
2 other studies available for beta-thujaplicin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Antimicrobial effect of oral care gel containing hinokitiol and 4-isopropyl-3-methylphenol against intraoral pathogenic microorganisms.
Topics: Antifungal Agents; Candida; Candida albicans; COVID-19; Gels; Gentian Violet | 2023 |
A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections.
Topics: Anti-Infective Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Homeostasis; Humans; Hyd | 2020 |